Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Retinoblastoma 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Lung Neoplasms 1 Infertility, Female 1 Hypoxia 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 6 pimonidazole 4 fluoroazomycin arabinoside 4 TH 302 4 Radiotherapy 4 Propofol 3 Injections 3 Positron Emission Tomography Computed Tomography 2 Drug Therapy 2 Blood Specimen Collection 2 Bacterial Load 2 pomalidomide 1 pembrolizumab 1 inositol trispyrophosphate 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 alovudine 1 Tirapazamine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Paclitaxel 1 Oxygen 1 Nitroglycerin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Nitroglycerin × Clear all

NCT01210378 2019-02-15

Nitroglycerin

Maastricht Radiation Oncology

Phase 2 Terminated

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡